Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Scheidhauer

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Nuclear Medicine Communications|September 1, 1988
Immunoscintigraphy in intraocular malignant melanomaK Scheidhauer, A Markl, G Leinsinger, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine|November 9, 2010
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphomaA Grgic, U Nestle, K Scheidhauer, et al.
Der Urologe. Ausg. A|November 26, 2016
[Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure]M E Autenrieth, T Horn, F Kurtz, et al.
Nuklearmedizin. Nuclear Medicine|July 3, 1998
[Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta]K Schomäcker, T Fischer, B Böttcher, et al.
European Journal of Nuclear Medicine|January 19, 2000
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyF Grünwald, T Kälicke, U Feine, et al.
Annals of Hematology|January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's diseaseM R Weihrauch, D Re, S Bischoff, et al.
Nuklearmedizin. Nuclear Medicine|February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]C Boy, T Poeppel, J Kotzerke, et al.
EJNMMI Research|January 25, 2018
Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018K Binzel, A Adelaja, C L Wright, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Nuclear Medicine Communications|September 1, 1988
Immunoscintigraphy in intraocular malignant melanomaK Scheidhauer, A Markl, G Leinsinger, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine|November 9, 2010
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphomaA Grgic, U Nestle, K Scheidhauer, et al.
Der Urologe. Ausg. A|November 26, 2016
[Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure]M E Autenrieth, T Horn, F Kurtz, et al.
Nuklearmedizin. Nuclear Medicine|July 3, 1998
[Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta]K Schomäcker, T Fischer, B Böttcher, et al.
European Journal of Nuclear Medicine|January 19, 2000
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyF Grünwald, T Kälicke, U Feine, et al.
Annals of Hematology|January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's diseaseM R Weihrauch, D Re, S Bischoff, et al.
Nuklearmedizin. Nuclear Medicine|February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]C Boy, T Poeppel, J Kotzerke, et al.
EJNMMI Research|January 25, 2018
Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018K Binzel, A Adelaja, C L Wright, et al.
Pageof 7